CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 42 filers reported holding CIDARA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $389,288 | +723.8% | 306,526 | +390.6% | 0.00% | – |
Q4 2022 | $47,255 | +136.3% | 62,482 | +53.8% | 0.00% | – |
Q2 2022 | $20,000 | -76.7% | 40,625 | +34.5% | 0.00% | – |
Q3 2020 | $86,000 | -69.3% | 30,195 | -60.2% | 0.00% | – |
Q2 2020 | $280,000 | +250.0% | 75,817 | +135.9% | 0.00% | – |
Q1 2020 | $80,000 | – | 32,138 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
Prosight Management, LP | 245,764 | $578,000 | 0.30% |